Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital

Abstract

BackgroundThe purpose of this study was to determine the shifting trends in bacteriology and antimicrobial resistance of infectious specimens isolated from gastrointestinal (GI) fistula patients over eight years in China.MethodsWe retrospectively reviewed the microbial records of intra-abdominal specimens at a teaching hospital from 2008 to 2015. Study period was divided into the first half (2008–2011) and the second half (2012–2015). All isolates underwent antibiotic susceptibility testing by the micro dilution method.ResultsA total of 874 intra-abdominal isolates were consecutively collected from 502 GI fistula patients (mean age, 46.5 years, 71.1% male) during the study period. Patients in the second study period (2012–2015) were older (>65 years) and more likely to have experienced cancer. Over the entire study period, most infections were caused by E. coli (24.2%) and K. pneumonia (14.1%). There was a significant decrease in the proportion E. coli isolates that were extended- spectrum beta-lactamase (ESBL)-positive (P = 0.026). The proportion of E. coli resistant to imipenem increased from 14.3% in 2008–2011 to 25.9% in 2012–2015 (P = 0.037). Imipenem resistance prevalence was higher in ESBL-negative bacteria than ESBL-positive bacteria for both E. coli and K. pneumonia (P < 0.001). In Enterococcus, significant increase in resistance to ampicillin (P = 0.01) and moxifloxacin (P = 0.02) over time were observed. In Staphylococcus and fungi, rates of antibiotic resistance did not significantly change over the study period.ConclusionsGram-negative bacteria predominated as causative agents of intra-abdominal infections in GI fistula patients, and there was an increase in levels of resistance to certain antibiotics, particularly carbapenems. Infection control and source control are important tools available to surgeons to prevent the emergence of antibiotic-resistant pathogens.Electronic supplementary materialThe online version of this article (10.1186/s12879-017-2744-7) contains supplementary material, which is available to authorized users.

Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China

“…However, data from 2015 showed K. pneumoniae IAI isolate susceptibilities between 80 and 90% to IPM and ETP in our study, which was much higher than the 43.24% susceptibility to IPM reported for K. pneumoniae IAI isolates from a Chinese tertiary-care hospital between 2012 and 2015 [ 15 ], but was in a similar range to Chinese isolates from abdominal trauma-associated IAI collected between 2010 to 2015, with susceptibilities of K. pneumoniae strains to IPM and ETP of 87.5–90.6% [ 16 ].…”

Isolation and Antimicrobial Susceptibility Pattern of Microorganisms Causing Intra-Abdominal Infections at Tertiary Care Hospital of Northern India

“…This study correlates with another study done by Liu et al which showed 100% sensitivity to Vancomycin and Linezolid, while High-level resistant was shown in Penicillin (93.34%), Erythromycin (84.62%), and Ciprofloxacin (73.68%) [16].…”

Na + -NQR Confers Aminoglycoside Resistance via the Regulation of l- Alanine Metabolism

“…Within a relatively short time after the first antibiotics were introduced, bacteria began exhibiting various degrees of resistance ( 1 ). Antibiotic resistance is a global challenge that impacts all pharmaceutically used antibiotics ( 2 , 3 ). In response to the emergent antibiotic resistance, novel strategies are needed to develop new antibiotics, vaccines, and bacitracin ( 4 – 9 ) and to enhance the effectiveness of existing antibiotics ( 10 – 13 ).…”